Suppr超能文献

血清 PACAP 水平与偏头痛发作:观察性研究的系统评价和荟萃分析。

Blood serum levels of PACAP and migraine onset: A systematic review and meta-analysis of observational studies.

机构信息

Department of Neurology, The Affiliated Hospital of Yunnan University, Kunming, P. R. China.

School of Clinical Medicine, Dali University, Dali, P. R. China.

出版信息

Headache. 2024 May;64(5):573-588. doi: 10.1111/head.14711. Epub 2024 Apr 24.

Abstract

OBJECTIVE

We conducted a systematic review and meta-analysis to explore the relationship between blood pituitary adenylate cyclase-activating polypeptide (PACAP) levels and migraine.

BACKGROUND

PACAP is involved in the onset of migraine, but the results from clinical studies on PACAP level variations across different periods of migraine are conflicting.

METHODS

We systematically searched for observational studies that reported PACAP levels in people with migraine and non-migraine controls published in English from the PubMed, Web of Science, and Ovid electronic databases, or in Chinese from the Chinese National Knowledge Infrastructure and the WanFang Med database. The Newcastle-Ottawa Quality Assessment Scale was used to assess the quality of the included studies. The quality of evidence for each outcome was assessed according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) guidelines.

RESULTS

Of the 514 identified studies, 8 were eligible for inclusion. There was a "very low" level of evidence suggesting that the PACAP level is negatively correlated with migraine disease duration in adults with migraine (summary = -0.35, 95% confidence interval [CI] -0.49 to -0.22) and that the PACAP is higher in people with migraine during the ictal period than in the interictal period (standardized mean difference = 0.41, 95% CI 0.17 to 0.66) for both adults and children with migraine. Adult patients with episodic migraine (weighted mean difference [WMD] = -9.58 pg/mL, 95% CI -13.41 to -5.75 pg/mL) or chronic migraine (WMD = -10.93 pg/mL, 95% CI -15.57 to -6.29 pg/mL) had lower blood PACAP levels than non-migraine controls during the interictal period, supported by a "low" or "very low" quality of evidence, respectively, according to the GRADE rules.

CONCLUSION

There is a very low certainty of evidence suggesting that the PACAP level is negatively correlated with migraine disease duration of adults with migraine and it varies greatly among different periods of migraine of both adults and children with migraine.

摘要

目的

我们进行了一项系统评价和荟萃分析,以探讨垂体腺苷酸环化酶激活肽(PACAP)水平与偏头痛之间的关系。

背景

PACAP 参与偏头痛的发作,但偏头痛不同时期 PACAP 水平变化的临床研究结果存在矛盾。

方法

我们系统地检索了在 PubMed、Web of Science 和 Ovid 电子数据库中以英文发表的或在中国知网和万方数据库中以中文发表的关于偏头痛患者和非偏头痛对照者 PACAP 水平的观察性研究,使用纽卡斯尔-渥太华质量评估量表评估纳入研究的质量。根据推荐、评估、发展和评价(GRADE)指南,对每个结局的证据质量进行评估。

结果

在 514 项确定的研究中,有 8 项符合纳入标准。有“极低”质量证据表明,PACAP 水平与偏头痛患者的偏头痛病程呈负相关(成人偏头痛患者的汇总值为-0.35,95%置信区间 [CI] -0.49 至-0.22),以及偏头痛发作期患者的 PACAP 水平高于间歇期(成人和儿童偏头痛患者的标准化均数差 [SMD] 分别为 0.41,95%CI 0.17 至 0.66)。发作性偏头痛(加权均数差 [WMD] = -9.58 pg/mL,95%CI -13.41 至-5.75 pg/mL)或慢性偏头痛(WMD = -10.93 pg/mL,95%CI -15.57 至-6.29 pg/mL)患者的间歇期血 PACAP 水平低于非偏头痛对照者,证据质量分别为“低”或“极低”,符合 GRADE 规则。

结论

有极低确定性证据表明,PACAP 水平与偏头痛患者的偏头痛病程呈负相关,且在成人和儿童偏头痛的不同时期变化很大。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验